China Universal Asset Management Company’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338K | Buy |
19,739
+276
| +1% | +$4.72K | 0.03% | 277 |
|
|
2025
Q1 | $1.24M | Sell |
19,463
-791
| -4% | -$50.5K | 0.12% | 160 |
|
|
2024
Q4 | $2.46M | Buy |
20,254
+1,912
| +10% | +$232K | 0.23% | 90 |
|
|
2024
Q3 | $2.29M | Buy |
18,342
+7,237
| +65% | +$904K | 0.25% | 84 |
|
|
2024
Q2 | $1.75M | Sell |
11,105
-6,923
| -38% | -$1.09M | 0.25% | 75 |
|
|
2024
Q1 | $2.33M | Buy |
18,028
+7,204
| +67% | +$933K | 0.3% | 75 |
|
|
2023
Q4 | $1.04M | Buy |
10,824
+8,427
| +352% | +$813K | 0.2% | 106 |
|
|
2023
Q3 | $291K | Buy |
2,397
+1,176
| +96% | +$143K | 0.08% | 127 |
|
|
2023
Q2 | $140K | Buy |
1,221
+29
| +2% | +$3.32K | 0.04% | 143 |
|
|
2023
Q1 | $164K | Buy |
1,192
+300
| +34% | +$41.3K | 0.06% | 119 |
|
|
2022
Q4 | $116K | Buy |
892
+72
| +9% | +$9.33K | 0.05% | 118 |
|
|
2022
Q3 | $91K | Buy |
+820
| New | +$91K | 0.04% | 112 |
|